News – Page 339
-
Business
DuPont overcomes investor challenge
Shareholders decline to elect activist board nominees in a show of support for the current management’s strategy
-
NewsUN sets its sights on marine microplastics
Scale of the problem means no simple solutions exist to tackle plastic particles already in the world’s oceans
-
NewsUniversities bear brunt of cuts to keep Australian science running
Cuts to funding for researchers announced in budget staves off infrastructure closures
-
BusinessTrade agreement could limit access to medicines
If approved in its leaked form, the Trans-Pacific Partnership would pose barriers for generic drugs to enter the market and keep drug prices high, warns the Foundation for Aids Research
-
NewsPanel of top scientists set to advise European commission
Announcement ends uncertainty over scientific advice after chief scientific adviser post scrapped
-
Business
Injunction blocks first US biosimilar
Despite regulatory approval, Amgen is delaying sales of Sandoz’s version of filgrastim
-
ResearchGraphene-wrapped diamond ball bearings cut friction to virtually nothing
Discovery could help save energy and money, but still needs to overcome limitations in humid conditions
-
News
California demands warning labels for BPA
Despite safety evidence, the state has added BPA to its list of cancer-linked chemicals under ‘Proposition 65’
-
Business
FDA accused of violating drug company’s freedom of speech
Amarin says the regulator is stopping it from giving ‘truthful, not misleading’ information to doctors about its fatty acid drug
-
ResearchEspresso maker brews up tasty extraction
Household appliance isolates flu drug raw material from star anise while minimising pigment contamination
-
ResearchElectricity harvested from magnetic noise
Magneto–mechano–electric generator could be effective power source for wireless charging
-
NewsTory election victory heralds new science minister for UK
David Cameron’s cabinet reshuffle ushers in new faces for research and universities posts
-
Business
Alexion to buy Synageva for rare disease drugs
$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
NewsGreenhouse gas milestone exceeded
Global carbon dioxide levels have passed 400ppm for the first time, according to new data from the US
-
NewsScientists protest over political firing of Russian chemist
Leading chemist dismissed after criticising federal science agency
-
Business
Zoetis to sell or close 10 plants in cost-cutting drive
Animal health firm will slash product portfolio in a bid to save $300m annually
-
ResearchTerpene analogues bear safer pesticides
Synthetic biology route to new versions of natural products, with surprising biological activities
-
NewsScientists call for ban on fluorinated chemicals
The Madrid Statement, signed by 200 scientists, urges consumers to avoid PFAS-containing products
-
ResearchChemists snare 17-electron half-sandwich radical
Important organometallic complex finally isolated and characterised after 40-year pursuit